• News Archive
  • Simaster
  • Webmail
  • Directory
  • Crisis Center
  •  English
    • Indonesia
Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada Universitas Gadjah Mada
  • Education
    • Doctoral dissertation
    • Inauguration of Professor
    • Graduation
  • Achievement
  • Research and Innovation
    • Research
    • Innovation
  • Campus Info
    • Cooperation
    • Seminar and Workshop
    • Student Community Service Program
    • Other
  • News Report
  • Home
  • News Report
  • UGM Develops New Rotavirus Vaccine

UGM Develops New Rotavirus Vaccine

  • 23 February 2018, 11:03 WIB
  • By: Marwati
  • 1661
UGM Berhasil Kembangkan Vaksin Rotavirus Baru Bagi Bayi Baru Lahir

Universitas Gadjah Mada (UGM) has developed new rotavirus vaccines, RV3-BB, which gives early protection to infants and young children from diarrhea caused by rotavirus.

The vaccine developed by researchers from Faculty of Medicine, Public Health, and Nursing UGM as well as from Murdoch Children’s Research Institute (MCRI) Australia has proved to be able to reduce inflammation in severe rotavirus gastroenteritis in infants.

Reportedly, rotavirus still causes severe diarrhea. Globally, rotavirus has caused fatalities of 215,000 toddlers. In Indonesia the disease is predicted to have caused 10,000 child mortality, 200,000 in-patients, and 600,000 out-patients each year.

Regional chairperson for gastroenterology and rotavirus research in Indonesia, Prof.dr. Yati Soenarto, Sp.A (K)., Ph.D., said rotavirus vaccine was introduced by Ruth Bishop from MCRI in 1973. Later on, UGM and MRCI were developing new types of RV3 oral to be given to new babies.

“The rotavirus vaccines circulating today can only be given to babies over six weeks old, so new babies are vulnerable to rotavirus infection. This new vaccine can be given to all babies soon after they are born,” she said in a press conference on Tuesday (22/2) at the Faculty.

Yati said that by giving the vaccine after the birth can give protection to the baby against such fatal disease at the third month. Not a few babies missed the vaccines opportunity so they have very high risk to severe rotavirus.

The new vaccine has been clinically tested in 25 health community centres and hospitals in Sleman, Yogyakarta, and Klaten. The vaccines is given to 1,649 babies in the first five days until 18 months in three single dosages.

“After three dosages of RV3-BB are given during birth, 94 percent of babies are protected in the first year against acute rotavirus gastroenteritis and 75 percent of babies protected until 18 months old,” said the main researcher of the clinical test of rotavirus vaccine in Indonesia, dr. Jarir At Thobari, Ph.D.

The test was the final phase and achievement of research that had begun since the 1990s in Australia. The first phase research was done in Melbourne and New Zealand and it proved to know immune system response to vaccines and ability to protect severe diarrhea in babies. Furthermore, research was done in Indonesia since 2013 to 2016 to know the efficacy of the vaccine in reducing rotavirus gastroenteritis in babies.

It is planned the vaccine will be produced massively in 2020, collaborating with PT. Bio Farma. “RV3-BB vaccine is expected to get into the National Immunisation Programme,” said Jarir.

 

Related News

  • Scientists at UGM Develop RV3-BB Rotavirus Vaccine

    Tuesday,16 May 2023 - 13:54
  • UGM Students Win SPORA Scientific Competition

    Tuesday,17 October 2017 - 15:55
  • Prof. Yati Soenarto Receives Bakrie Award 2010

    Wednesday,18 August 2010 - 10:42
  • UGM Students Make Anti-Fake-Vaccine Application

    Monday,14 August 2017 - 11:45
  • Vaccinated People Have a Low Covid-19 Risk

    Friday,15 January 2021 - 10:46

News Releases

  • UGM to Bolster Cooperation With US Partners 31 May 2023
    UGM enhances cooperation in education, research, a
    Salma
  • GIS Student Wins 3 Medals at 2023 National Olympiad 31 May 2023
    UGM Geographic Information System student Hajir Helmi Nur
    Salma
  • Biology Students Grab 2 Prizes in Indonesia-Wide Scientific Writing Competition 26 May 2023
    A team from the UGM Faculty of Biology has won two
    Salma
  • Professor Ika Dewi Ana Receives WIPO National Award for Inventors 22 May 2023
    Professor Ika Dewi Ana from the UGM Faculty of Den
    Salma
  • Civil Engineering Students Win International BIM Innovation Contest CEIC XI 22 May 2023
    Three UGM Civil Engineering students, teaming up a
    Salma

Event

  • 06Sep The 5th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC) 2023...
  • 02Oct Conference of Critical Island Studies...
  • 04Oct The 7th Astechnova International Energy Conference...
Universitas Gadjah Mada
UNIVERSITAS GADJAH MADA
Bulaksumur Yogyakarta 55281
   info@ugm.ac.id
   +62 (274) 588688
   +62 (274) 565223
   +62 811 2869 988

PARTNERSHIP

  • Alumni
  • International Affairs

ABOUT UGM

  • Rector's Welcome
  • History
  • Vission and Mission
  • The Board of Executive
  • Management

VISIT UGM

  • Campus Map
  • Event

REGISTRATION

  • Undergraduate
  • Graduate
  • Vocational School
  • Professional Program
  • International Program

© 2023 Universitas Gadjah Mada

PRIVACY POLICYCONTACT